Literature DB >> 11277547

Cancer screening guidelines.

R Zoorob1, R Anderson, C Cefalu, M Sidani.   

Abstract

Numerous medical organizations have developed cancer screening guidelines. Faced with the broad, and sometimes conflicting, range of recommendations for cancer screening, family physicians must determine the most reasonable and up-to-date method of screening. Major medical organizations have generally achieved consensus on screening guidelines for breast, cervical and colorectal cancer. For breast cancer screening in women ages 50 to 70, clinical breast examination and mammography are generally recommended every one or two years, depending on the medical organization. For cervical cancer screening, most organizations recommend a Papanicolaou test and pelvic examination at least every three years in patients between 20 and 65 years of age. Annual fecal occult blood testing along with flexible sigmoidoscopy at five-year to 10-year intervals is the standard recommendation for colorectal cancer screening in patients older than 50 years. Screening for prostate cancer remains a matter of debate. Some organizations recommend digital rectal examination and a serum prostate-specific antigen test for men older than 50 years, while others do not. In the absence of compelling evidence to indicate a high risk of endometrial cancer, lung cancer, oral cancer and ovarian cancer, almost no medical organizations have developed cancer screening guidelines for these types of cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11277547

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  26 in total

1.  Racial differences in PSA screening interval and stage at diagnosis.

Authors:  William R Carpenter; Daniel L Howard; Yhenneko J Taylor; Louie E Ross; Sara E Wobker; Paul A Godley
Journal:  Cancer Causes Control       Date:  2010-03-24       Impact factor: 2.506

2.  Cancer preventive screening: a cross-border comparison of United States and Canadian Chinese women.

Authors:  Shin-Ping Tu; Sara L Jackson; Yutaka Yasui; Michéle Deschamps; T Gregory Hislop; Vicky M Taylor
Journal:  Prev Med       Date:  2005-07       Impact factor: 4.018

3.  Family health information sharing among older adults: reaching more family members.

Authors:  Sato Ashida; Ellen J Schafer
Journal:  J Community Genet       Date:  2014-07-30

4.  Colorectal cancer screening among obese versus non-obese patients in primary care practices.

Authors:  Jeanne M Ferrante; Pamela Ohman-Strickland; Shawna V Hudson; Karissa A Hahn; John G Scott; Benjamin F Crabtree
Journal:  Cancer Detect Prev       Date:  2006-10-25

5.  Changing trends in the incidence of ovarian neoplasia and its relationship with the risk factors: a report of 311 cases from north-eastern anatolia region.

Authors:  Elif Demirci; Ferah Tuncel Daloglu; Muhammet Calik; Eren Altun; Sare Sipal; Bunyamin Borekci
Journal:  Eurasian J Med       Date:  2014-08-26

6.  Informed decision making changes test preferences for colorectal cancer screening in a diverse population.

Authors:  Navkiran K Shokar; Carol A Carlson; Susan C Weller
Journal:  Ann Fam Med       Date:  2010 Mar-Apr       Impact factor: 5.166

7.  Factors associated with a physician's recommendation for colorectal cancer screening in a diverse population.

Authors:  Navkiran K Shokar; Tracy Nguyen-Oghalai; Helen Wu
Journal:  Fam Med       Date:  2009-06       Impact factor: 1.756

8.  Patient education cards for skin cancer detection and treatment.

Authors:  Ryan D Kauffman; Mrunal S Shah; Ross M Kauffman
Journal:  J Cancer Educ       Date:  2010-06       Impact factor: 2.037

9.  Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use.

Authors:  William R Carpenter; Paul A Godley; Jack A Clark; James A Talcott; Timothy Finnegan; Merle Mishel; Jeannette Bensen; Walter Rayford; L Joseph Su; Elizabeth T H Fontham; James L Mohler
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

10.  Lack of follow-up of prostate-specific antigen test results.

Authors:  Stephanie L McFall; David W Smith
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.